PAREXEL Consulting

PAREXEL Consulting
Share

PAREXEL Consulting

 •  December 21, 2017

Solution now features Clinical Metadata Repository to meet evolving data standards while providing seamless and more timely workflow for clients from data collection, through analysis to submission BOSTON, December 18, 2017 – PAREXEL International Corporation, a leading global biopharmaceutical services provider, today introduced its enhanced...

PAREXEL Consulting

 •  November 16, 2017

New Appointments Enhance PAREXEL’s Leadership and Expertise
in Bringing Commercially Viable, Reimbursable Products to Market BOSTON, November 15, 2017 — PAREXEL, a leading global biopharmaceutical services provider, today announced the appointment of three former senior regulatory consulting executives from the U.S. Food and Drug Administration...

PAREXEL Consulting

 •  October 26, 2017

Market-first feature leverages mobile and sensor technology via PAREXEL’s ClinPhone® RTSM mobile app to prevent temperature-compromised medication from reaching clinical trial patients
BOSTON, October 26, 2017 – PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced a new feature for its...

PAREXEL Consulting

 •  September 29, 2017

BOSTON, September 29, 2017 - PAREXEL International Corporation (NASDAQ: PRXL) ("PAREXEL" or the "Company"), a leading global biopharmaceutical services company, announced that Pamplona Capital Management, LLP (“Pamplona”) completed its acquisition of PAREXEL today. Pamplona acquired all outstanding shares of PAREXEL for $88.10 per share in cash....

PAREXEL Consulting

 •  June 19, 2017

Features new ForeSite™ clinical trial methodology designed to reliably predict site success BOSTON, June 19, 2017 – As life science companies increasingly seek to gain insights from diverse data sources to make drug development more efficient and effective, PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical...

PAREXEL Consulting

 •  June 15, 2017

Preliminary findings from pilot study validate use of wearable technologies to collect data and manage clinical trials more effectively and efficiently BOSTON, June 15, 2017 –PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced a collaboration with Sanofi to advance the use of...

PAREXEL Consulting

 •  November 30, 2016

This presentation will be available to audience members until Monday, August 28, 2017 at 12:00 PM Eastern Daylight Time. Spirometry data is pivotal to assessing primary or secondary outcomes in most respiratory trials, but implementation in a clinical trial varies by sponsor and service provider. A significant portion of spirometry data in clinical...